Internal Medicine, Hematology & Oncology · Orange, CA
NPI
1407881592
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
101 the City Dr S
Orange, CA, 92868
Phone (832) 909-5763
Groups this clinician bills Medicare through
Medicare paid, 2024
$58K
523 services
Medicare patients, 2024
69
Average age 73
Drug cost, 2024
$1.1M
561 prescriptions
Company payments, 2025
$6,771
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kiran Naqvi was code 99233 (hospital e&m - subsequent), 215 times for 36 patients. In total Kiran Naqvi billed 523 services in 13 codes, and Medicare paid $58K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 215 | 36 | $102.90 | $22K |
| 99215 Office E&M - Established | Facility | 193 | 35 | $124.25 | $24K |
| 99214 Office E&M - Established | Facility | 37 | 14 | $86.71 | $3,208 |
| 99223 Hospital E&M - Initial | Facility | 19 | 18 | $147.23 | $2,797 |
| 99238 Hospital Discharge Management | Facility | 14 | 14 | $72.86 | $1,020 |
By year: 2023 $46K for 436 services; 2024 $58K for 523 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kiran Naqvi prescribed most often to Medicare patients was Acyclovir, with 70 prescriptions and refills. In total Kiran Naqvi wrote 561 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 70 | 95 | 20 | $1,432 |
| Levofloxacin Generic | 62 | 72 | 15 | $599 |
| Posaconazole Generic | 49 | 49 | 12 | $68K |
| Venclexta Venetoclax | 31 | 31 | Under 11 | $27K |
| Potassium Chloride Generic | 31 | 39 | Under 11 | $593 |
| Iclusig Ponatinib Hcl | 31 | 31 | Under 11 | $626K |
| Pantoprazole Sodium Generic | 28 | 32 | Under 11 | $224 |
| Furosemide Generic | 17 | 24 | Under 11 | $46.22 |
| Allopurinol Generic | 15 | 25 | Under 11 | $116 |
| Lisinopril Generic | 14 | 36 | Under 11 | $50.45 |
| Gabapentin Generic | 13 | 15 | Under 11 | $152 |
| Rabeprazole Sodium Generic | 11 | 11 | Under 11 | $212 |
| Famotidine Generic | 11 | 11 | Under 11 | $122 |
Brand drugs: - claims; generic drugs: 441 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kiran Naqvi $6,771 ($6,771 in general payments such as food, travel and fees) from 6 companies. The largest payer was Geron Corporation with $3,375.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.